Concepedia

Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil

Arun Chandrakantan, Piti Ratanapanichkich, Mowaffaq Said, Catherine V. Barker, Bruce A. Julian

Nephrology Dialysis Transplantation · 2005 · 75 citations · 16 references

Abstract

Mycophenolate mofetil, compared with azathioprine, did not lessen the recurrence of IgAN or its clinical impact.

References

16

PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

Josep M. Grinyó, CG Groth, R. Pichlmayr et al. · Data Archiving and Networked Services (DANS) · 1995 · 979 citations

RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

Naoyuki Nakao, Ashio Yoshimura, Hiroyuki Morita et al. · The Lancet · 2003 · 977 citations

Hypertension, Urology, Diabetes Management +10

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection

The Lancet · 1995 · 929 citations

Mycophenolate Mofetil, Clinical Therapeutic, Medicine +5

Predicting renal outcome in IgA nephropathy.

M. Gene Radford, James V. Donadío, Eric J. Bergstralh et al. · Journal of the American Society of Nephrology · 1997 · 440 citations

Glomerular Disease, Renal Outcome, Renal Pathology +24

Treatment of IgA Nephropathy with ACE Inhibitors

Manuel Praga, Eduardo Gutiérrez, Ester González et al. · Journal of the American Society of Nephrology · 2003 · 343 citations